TITLE

Correction

PUB. DATE
June 2011
SOURCE
American Journal of Health-System Pharmacy;6/1/2011, Vol. 68 Issue 11, p960
SOURCE TYPE
Academic Journal
DOC. TYPE
Correction notice
ABSTRACT
No abstract available.
ACCESSION #
61141605

 

Related Articles

  • Correction.  // Pharmaceutical Representative;Dec2005, Vol. 35 Issue 12, p10 

    A correction to the article on the approval of Laborpharm Inc.'s extended-release tramadol product that was published in the November 2005 issue was presented.

  • Correction.  // Nature Medicine;Mar2012, Vol. 18 Issue 3, p337 

    A correction to the article "Class of once-weekly diabetes drugs poised for approval" in the December 2011 issue is presented.

  • Corrigendum.  // WHO Drug Information;2010, Vol. 24 Issue 2, p90 

    A correction to the article "WHO Prequalification of Medicines Programme: Facts and Figures for 2009" that was published in a previous issue of the journal is presented.

  • Corrections.  // Review of Ophthalmology;Dec2009, Vol. 16 Issue 12, p6 

    Corrections to articles published in the November 2009 issue are presented including the "Management of Retinal Vein Occlusion" and the U.S. Food and Drug Administration's approval to Sirion Therapeutics Inc.'s Durezol.

  • Pipeline preview.  // Formulary;Sep2003, Vol. 38 Issue 9, p512 

    Reports on developments related to drug approvals in the U.S. Designation of Timolol for the treatment of glaucoma; List of orphan drug designations.

  • Drugs in the News.  // Clarendon Enterprise (TX);4/24/2008, Vol. 19 Issue 17, p7 

    The article reports on the approval of a new facial wrinkle filler, Prevelle Silk, by the U.S. Food and Drug Administration (FDA) in the U.S.

  • 2007 Drug Approvals.  // American Journal of Health-System Pharmacy;2/1/2008, Vol. 65 Issue 3, p192 

    The article lists new molecular entities (NMEs) and new biological products for 2007 in the U.S. which include Nebivolol hydrochloride oral tablets for the treatment of hypertension, Ambrisentan oral tablets for the treatment of pulmonary arterial hypertension, and Thrombin as an aid to...

  • NEW DRUGS.  // Drug Topics;3/3/2003, Vol. 147 Issue 5, p94 

    Reports on drugs approved in the United States. Auxilium Pharmaceuticals' Testim drug for treating low levels of testosterone in men; Bradley Pharmaceuticals division, Kenwood Therapeutics' hemorrhoid therapy, AnaMantle HC.

  • NEW FORMULATIONS.  // Drug Topics;3/3/2003, Vol. 147 Issue 5, p94 

    Reports on drugs approved in the United States. Biovail Corp.'s cardizem LS, a long-acting formulation of the calcium-channel blocker indicated for control of hypertension; Muscle relaxant, Flexeril from McNeil Consumer & Specialty Pharmaceuticals.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics